Literature DB >> 7965433

Plasma cysteine concentrations in infants with respiratory distress.

C W White1, S P Stabler, R H Allen, S Moreland, A A Rosenberg.   

Abstract

Because factors that predispose infants to persistent pulmonary hypertension of the newborn (PPHN) may cause oxidant stress, which in turn may increase demands for cysteine and glutathione, we investigated the availability of cysteine and its precursors in PPHN and related disorders. Plasma concentrations of four sulfur-containing and two non-sulfur-containing amino acids were measured by gas chromatography-mass spectrometry in blood from infants with PPHN, both those managed conventionally (PPHN group) and those treated with extracorporeal membrane oxygenation, as well as from infants with hyaline membrane disease. Concentrations also were measured in umbilical venous cord blood samples from a healthy control population, in venous plasma from infants receiving only intravenously administered glucose-containing solutions because they had noncardiopulmonary illnesses ("fasted" group), and from otherwise healthy, orally fed infants ("fed" group). The plasma total cyst(e)ine concentration was markedly lower in the three groups (PPHN, PPHN and extracorpeal membrane oxygenation, and hyaline membrane disease) receiving an elevated inspired oxygen concentration (0.6 to 1.0) than in fasted or fed control infants. In contrast, levels of plasma methionine, the other major sulfur amino acid, were low in the three groups receiving an elevated inspired oxygen concentration, as well as in fasted infants. Glycine and serine, two non-sulfur-containing amino acids, had a pattern similar to that of plasma methionine. Thus infants with PPHN and hyaline membrane disease have low plasma total cyst(e)ine levels, an effect that does not appear to result primarily from nutritional deprivation. We speculate that the role of cysteine in bioactivation of nitric oxide and as a precursor of glutathione may be relevant to the pathogenesis and evolution of PPHN and respiratory distress syndrome. Further studies are needed to determine whether increased demands for cysteine exist in these disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965433     DOI: 10.1016/s0022-3476(94)70077-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Pulmonary hypertension associated with nonketotic hyperglycinaemia.

Authors:  S Cataltepe; L J van Marter; H Kozakewich; D L Wessel; P J Lee; H L Levy
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

2.  Effect of High-Dose Cysteine Supplementation on Erythrocyte Glutathione: A Double-Blinded, Randomized Placebo-Controlled Pilot Study in Critically Ill Neonates.

Authors:  Kara L Calkins; Lauren A Sanchez; Chi-Hong Tseng; Kym F Faull; Alexander J Yoon; Christopher M Ryan; Thuc Le; Stephen B Shew
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-08-19       Impact factor: 4.016

3.  Comparison of Oxidative Stress Markers and Serum Cortisol between Normal Labor and Selective Cesarean Section Born Neonates.

Authors:  Rasoul Kaviany Nejad; Mohammad Taghi Goodarzi; Gholamreza Shfiee; Nasrolah Pezeshki; Maryam Sohrabi
Journal:  J Clin Diagn Res       Date:  2016-06-01

4.  Metabolism of methionine in the newborn infant: response to the parenteral and enteral administration of nutrients.

Authors:  Biju Thomas; Lourdes L Gruca; Carole Bennett; Prabhu S Parimi; Richard W Hanson; Satish C Kalhan
Journal:  Pediatr Res       Date:  2008-10       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.